Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Anal Neoplasm · Lassa Fever · INO

INOVIO Pharmaceuticals

INOVIO PHARMACEUTICALS, INC.

INOVIO Pharmaceuticals patent portfolio — 75 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US HQ
203 Employees
Public company Type
INO · NYSE Ticker
Company details
Status
Public
HQ
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US
Employees
203
Programs
46
Drugs
8
Patents
75
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

INOVIO Pharmaceuticals patents

75 pharmaceutical patents indexed for INOVIO Pharmaceuticals. 0 expire within 24 months.

INOVIO Pharmaceuticals has 75 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

75 patents

Patent portfolio

Page 1 of 2

  1. US 12285473

    Cancer vaccines targeting MUC16 and uses thereof

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12280108

    Vaccines having an antigen and interleukin-21 as an adjuvant

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12251561

    Minimally invasive dermal electroporation device

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12240872

    Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12161706

    Cancer vaccines targeting BORIS and uses thereof

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12109258

    Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12064473

    Cancer vaccines targeting Survivin and uses thereof

    Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12054537

    Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodies

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12053619

    Intradermal jet injection electroporation

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12049479

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11986517

    Cancer vaccines targeting mesothelin and uses thereof

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11980659

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11981724

    DNA antibody constructs for use against middle east respiratory syndrome coronavirus

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11925685

    DNA antibody constructs encoding anti-ZIKV envelope antibodies

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11896654

    DNA monoclonal antibodies targeting checkpoint molecules

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11865166

    Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11851477

    DNA monoclonal antibodies targeting influenza virus

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11844830

    Vaccines for human papilloma virus and methods for using the same

    Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11845787

    DNA antibody constructs for use against HIV

    Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11801288

    Cancer vaccines and methods of treatment using the same

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11801298

    MERS-CoV vaccine

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11744885

    Vaccines for recurrent respiratory papillomatosis and methods of using the same

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11660335

    Vaccines against coronavirus and methods of use

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11638747

    WT1 vaccine

    Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11565107

    Tolerable and minimally invasive skin electroporation device

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11464841

    TERT immunogenic compositions and methods of treatment using the same

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11338029

    Cancer vaccines targeting PRAME and uses thereof

    Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11338028

    Cancer vaccines targeting LEMD1 and uses thereof

    Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11291836

    Minimally invasive dermal electroporation device

    Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11278619

    DNA antibody constructs and method of using same

    Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11235044

    Cancer vaccines targeting MUC16 and uses thereof

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11230592

    DNA antibody constructs for use against middle east respiratory syndrome coronavirus

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11208470

    DNA antibody constructs and method of using same

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11154602

    Cancer vaccines targeting mesothelin and uses thereof

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11154601

    Cancer vaccines targeting BORIS and uses thereof

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11135284

    MERS-CoV vaccine

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11124545

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11116838

    Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11091518

    Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11045535

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11027071

    Intradermal jet injection electroporation device

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11007255

    Cancer vaccines and methods of treatment using the same

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11007265

    Vaccines having an antigen and interleukin-21 as an adjuvant

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10933130

    Vaccines with interleukin-33 as an adjuvant

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10925961

    Vaccines with CD40 ligand as an adjuvant

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10905755

    Vaccines for human papilloma virus and methods for using the same

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10835595

    PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10668279

    Miniminally invasive dermal electroporation device

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does INOVIO Pharmaceuticals have?

75 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do INOVIO Pharmaceuticals patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.